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RESEARCH
We studied the occurrence of variant Creutzfeldt-Jakob 
disease (vCJD) outside the United Kingdom in relation to 
the incidence of indigenous bovine spongiform encepha-
lopathy (BSE) and to the level of live bovines and bovine 
products imported from the UK during the 1980s and the 
fi rst half of the 1990s. Our study provides evidence that a 
country’s number of vCJD cases correlates with the number 
of live bovines it imported from the UK from 1980 to 1990 
(Spearman rank correlation coeffi cient [rs] 0.73, 95% confi -
dence interval [CI] 0.42–0.89, p<0.001). Similar correlations 
were observed with the number of indigenous BSE cases 
(rs  0.70, 95% CI 0.37–0.87, p = 0.001) and carcass meat 
imported from the UK from 1980 to 1996 (rs 0.75, 95% CI 
0.45–0.89; p<0.001) Bovine imports from the UK may have 
been an important source of human exposure to BSE and 
may have contributed to the global risk for disease.
In 1996 a new variant of Creutzfeldt-Jakob disease (vCJD) was described in the United Kingdom (1). By September 
2006, 196 cases had been reported worldwide; most (162, 
83%) occurred in the UK. Laboratory and epidemiologic 
studies provide strong circumstantial evidence for a causal 
link between vCJD and the bovine spongiform encepha-
lopathy (BSE) epizootic in cattle (2,3) with the most likely 
route of primary human infection being through dietary ex-
posure to highly infected bovine tissues (3).
In recent years, vCJD has been identifi ed in a number 
of European countries with indigenous outbreaks of BSE, 
including 20 cases of vCJD in France, 4 in Ireland, 2 in 
the Netherlands, and single cases in Portugal, Italy, and 
Spain. A growing number of cases of vCJD have also been 
identifi ed in countries outside Europe that have minimal 
incidence of BSE, including Japan, the United States, and 
Canada, and also in Saudi Arabia, a country in which BSE 
has not been identifi ed (4). Several of the non-UK patients, 
notably 2 Irish, 1 Canadian, 2 American, and possibly the 
Japanese patient, may have been infected during periods 
of residence in the UK, but most cases (28 of 34) occur-
ring outside the UK were in persons who had never visited 
the UK. Although vCJD cases have occurred in countries 
with very low incidence of BSE, no cases have been re-
ported in countries with higher incidence of BSE, such as 
Switzerland (460 reported cases of BSE) and Germany 
(395 cases) (5). This fact raises questions as to the source 
of infection in the vCJD cases outside the UK. Were the 
patients exposed to indigenous cases of BSE or to infected 
bovine material imported from the UK? An analysis of in-
fection risk in France suggests that the most likely source 
of vCJD in that country is imported infected material from 
the United Kingdom (6). In the Republic of Ireland, the 
transmission of BSE to humans was estimated to be equally 
likely from indigenous BSE or from UK imports (7). Given 
the apparently weak association between the occurrence of 
indigenous BSE and vCJD in some countries, we studied 
the occurrence of vCJD cases outside the UK in relation to 
the level of imported bovines and bovine products from the 
UK during the 1980s and the fi rst half of the 1990s.
Methods
A European Union (EU) surveillance network, estab-
lished in 1993, ensures prospective surveillance for CJD by 
using standard methods (8) in 18 European countries and 
the United States, Canada, Israel, and Australia. By August 
24, 2006, 32 cases of vCJD had been identifi ed in these 
countries (excluding the UK) (Table 1). Two more cases 
had been identifi ed in countries outside the surveillance 
network, Japan and Saudi Arabia. Case-patients in Canada 
(n = 1), the United States (n = 2), Ireland (n = 2), and pos-
sibly Japan (n = 1) were considered as likely to have been 
infected during periods of residence in the UK.
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Data on indigenous BSE cases detected by both pas-
sive and active surveillance were obtained from the World 
Organization for Animal Health webpage (www.oie.int/
eng/info/en_esbmonde.htm) (5). The number of live cattle 
and the tonnage of carcass meat exported from the UK were 
derived from UK Custom and Excise Data (9).
We included in our analysis all countries covered by 
the EU surveillance network. Because exposure was ex-
pressed as a total amount rather than per capita, we based 
the analysis on number of vCJD cases rather than rates. We 
plotted the incidence of vCJD (number of cases) by country 
against the following factors: 1) number of cases of indig-
enous BSE, 2) number of live bovines imported from the 
United Kingdom from 1980 to 1990, and 3) tonnage of car-
cass meat imported from the United Kingdom from 1980 
to 1996. For the last 2 plots, we used logarithmic scales to 
improve visualization of the data. 
We have included carcass meat data until 1996, when 
all UK bovine imports were banned by the EU. However, 
for live bovine imports we limited our analysis to the period 
1980–1990. In 1990 the EU restricted live bovine exports 
from the UK to animals <6 months of age and required that 
the importing country must ensure that any imported cattle 
from the UK were slaughtered at <6 months of age (10). 
For the correlation analyses, we included only the non-UK 
vCJD patients who are thought likely to have acquired in-
fection outside the UK. A factor likely to be important for 
BSE exposure is the temporal distribution of UK exports. 
The number of BSE-infected cattle entering the human food 
supply is estimated to have peaked in the UK around 1989 
(7), although with respect to exports, peak exposure may 
have been later, around 1992–1993. For example, 85% of 
Germany’s imports of UK carcass meat between 1980 and 
1990 were before 1988. In contrast, 70% of the livestock 
imports to the Netherlands were from 1987 through 1990. 
To account for this fact, we weighted the number of live 
bovines and the carcass meat tonnage imported each year 
by the size of the UK BSE epizootic that year (reported 
clinical cases) and normalized the data by the maximum 
number of BSE cases detected in a year during the epizo-
otic. Nonparametric Spearman rank correlation coeffi cients 
(rs) were calculated to evaluate whether evidence of a cor-
relation between exposure and outcome existed.
Results
Figure 1 shows a scatter plot of the number of cases 
of indigenous BSE in non-UK countries and the number of 
non-UK vCJD cases per country. Although the confi dence 
intervals (CIs) are wide, evidence of a correlation between 
these 2 variables (rs 0.70, 95% CI 0.37–0.87, p = 0.001) 
exists in the countries belonging to the EU network (Table 
2). When we included in our analysis Japan and Saudi Ara-
bia, the only 2 countries outside the EU network in which 
vCJD cases have been detected, the correlation coeffi cient 
fell to 0.55 (95% CI 0.17–0.79, p = 0.008) (Table 2). Non-
UK vCJD cases in EU network countries were also cor-
related with the number of live bovine imports from the 
UK (Figure 2; rs 0.73, 95% CI 0.42–0.89, p<0.001) and the 
amount of carcass meat imported from the UK (Figure 3; 
rs 0.75, 95% CI 0.45–0.89, p<0.001). Including Japan and 
Saudi Arabia produced similar results (live bovines rs 0.65, 
95% CI 0.31–0.84; carcass meat rs 0.73, 95% CI 0.45–0.88) 
(Table 2).
We evaluated whether our fi ndings were dependent on 
the data from France, which has the largest number of non-
UK cases, by repeating the analyses excluding France. Evi-
dence remained that all 3 exposures were correlated with 
vCJD incidence (Table 2). We also repeated the analysis 
including the 6 cases detected outside the UK but thought 
to have been acquired in the UK. The inclusion of these 
cases resulted in a reduction in all 3 correlation coeffi cients 
(Table 2).
Discussion
Live bovine and carcass meat imports from the United 
Kingdom during the 1980s and the fi rst half of the 1990s 
correlate with the numbers of vCJD cases in countries 
Table 1. Worldwide variant Creutzfeldt-Jakob disease cases as of 
August 2006 
Country of residence at disease onset N
United Kingdom 162
France 20
Republic of Ireland 2+2*
Italy 1
United States 2*
Canada 1*
Saudi Arabia 1
Japan 1*
The Netherlands 2
Portugal 1
Spain 1
*Most likely exposed to bovine spongiform encephalopathy in the UK. 
Figure 1. Scatter plot of the number of cases of indigenous bovine 
spongiform encephalopathy (BSE) in non–UK countries and the 
number of non-UK variant Creutzfeldt-Jakob disease (vCJD) cases 
per country. SA, Saudi Arabia.
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outside the UK. This fi nding suggests that live bovine and/or 
carcass meat imports from the UK may have been an im-
portant source of exposure in at least some of the countries 
in which vCJD has been detected. These results are con-
sistent with an analysis of data from France, which sug-
gested that UK bovine imports were likely to have been a 
more important source of infection than indigenous BSE 
(6). Thus, a proportion of cases observed to date outside the 
UK may have been acquired through imports from the UK 
rather than by the patients’ exposure to indigenous BSE. 
The inclusion in the analysis of the 6 non-UK case-patients 
thought to be infected in the UK reduced all 3 correlation 
coeffi cients, as one would expect if the supposition that 
they were infected in the UK is correct.
These fi ndings come with several important caveats. 
First, they are based on small numbers of vCJD cases. Even 
a small number of additional non-UK cases in the future 
could alter the fi ndings substantially. Furthermore, we have 
not performed multivariable analyses to determine which of 
the 3 exposures of interest were correlated with vCJD inci-
dence because we were concerned that the small number of 
cases might lead to unreliable results. Second, the analyses 
of imports are based on UK Customs and Excise data, not 
all of which been validated by importing countries. Even if 
these data are reasonably accurate, the actual level of BSE 
infection entering the human food chain in importing coun-
tries cannot be estimated because many important unknown 
variables exist, such as the age distribution of imported live 
bovines, the age at slaughter of these animals, the culinary 
habits in each country, and the possibility that some of the 
UK imports may have been re-exported to other countries. 
Third, indigenous BSE-infected cattle entering the food 
supply will have gone undetected until the introduction 
throughout the EU of the active abattoir testing program for 
BSE in 2000/2001; even now, cattle in the early stages of 
infection are unlikely to be detected. Furthermore, the effi -
ciency of BSE surveillance varies from country to country: 
underascertainment is likely in those countries with limited 
or no active testing programs.
It is noteworthy that none of the 162 UK patients 
with vCJD identifi ed up to September 2006 were born af-
ter 1989, the year in which the specifi ed bovine offal ban 
was introduced to minimize human exposure to BSE; how-
ever, 2 of the 34 non-UK vCJD case-patients were born 
after 1989. Measures equivalent to the UK ban on specifi ed 
bovine offals were not introduced in many continental Eu-
ropean countries until 2000.
Table 2. Results of nonparametric correlation analyses between number of variant Creutzfeldt-Jakob disease (vCJD) cases and the 3 
studied exposure sources* 
Exposure
Countries and vCJD case-patients 
included in analysis
Indigenous BSE cases
(CI, p value) 
Live bovines imported  
from UK, 1980–1990  
(CI, p value)† 
Carcass meat imported
from UK, 1980–1996  
(CI, p value)† 
All EU network countries 
 Patients likely to have been  
 infected in UK excluded 
rs = 0.70
(CI 0.37–0.87, p = 0.001) 
rs = 0.73
(0.42–0.89, p<0.001) 
rs = 0.75
(0.45–0.89, p<0.001) 
 Patients likely to have been  
 infected in UK included 
rs = 0.60
(0.21–0.82, p = 0.005) 
rs = 0.63 
(0.26–0.84, p = 0.003) 
rs = 0.64
(0.27–0.84, p = 0.003) 
All EU network countries plus Japan and Saudi Arabia 
 Patients likely to have been  
 infected in UK excluded 
rs = 0.55 
(0.17–0.79, p = 0.008)  
  rs = 0.65
(0.31–0.84, p = 0.001) 
rs = 0.73
(0.45–0.88, p<0.001) 
 Patients likely to have been  
 infected in UK included 
rs = 0.51 
(0.11–0.77, p = 0.02) 
rs = 0.52
(0.13–0.77, p = 0.01) 
  rs = 0.57
(0.19–0.80, p = 0.006) 
All countries except France 
 Patients likely to have been 
 infected in UK excluded 
rs = 0.48 
(0.06–0.75, p = 0.03) 
rs = 0.60
(0.23–0.81, p = 0.005) 
rs = 0.68
(0.36–0.86, p = 0.001) 
 Patients likely to have been  
 infected in UK included 
rs = 0.44 
(0.01–0.73, p = 0.05) 
rs = 0.44
(0.01–0.73, p = 0.05) 
rs = 0.49
(0.08–0.76, p = 0.02) 
*BSE, bovine spongiform encephalopathy; UK, United Kingdom; EU, European Union; CI, confidence interval; rs Spearman rank correlation coefficient. 
†Weighted by the temporal distribution of the export in relation to the size of the BSE epizootic in the UK. 
Figure 2. Scatter plot of live bovine imports (unweighted data) from 
the UK (1980–1990) and the number of non-UK variant Creutzfeldt-
Jakob disease (vCJD) cases per country. Values are logarithmic. 
SA, Saudia Aradia; M, million. 
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Despite these caveats, our results suggest that, globally, 
imports from the UK may have been an important source of 
infection and for some countries may even have been the 
main source. If this is so, our fi ndings have several impli-
cations. Past UK exports may be the major determinant of 
the current incidence of vCJD outside the UK. The greatest 
volume of these exports was to France, the Netherlands, 
and Ireland. Thus, initially at least, we might expect the 
largest number of vCJD cases to occur in these countries. 
However, exposure to BSE through imports from the UK 
ceased in 1996, and exposure to indigenous BSE is likely to 
have continued at some level until the measures introduced 
in 2000. Thus, the proportion of vCJD cases due to expo-
sure to indigenous BSE may increase with time.
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Figure 3. Scatter plot of the tonnage of carcass meat (unweighted 
data) imports from the United Kingdom (1980–1996) and the 
number of non-UK variant Creutzfeldt-Jakob disease (vCJD) cases 
per country. Values are logarithmic. SA, Saudia Aradia; M, million. 
